Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AdaptVac logo — AdaptVac aims to accelerate the development of safe and effi...

AdaptVac

AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines

Founded 2017 Denmark Denmark 10 employees Grant Total: $800.00K Biotechnology, Health Care +1

General Information

Company Name AdaptVac
Founded Year 2017
Location Denmark Denmark
Founders / Decision Makers
Team member
Employees 10
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with AdaptVac. To contact AdaptVac, visit adaptvac.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About AdaptVac

AdaptVac is a biotechnology startup with a strong focus on accelerating the development of safe and efficacious therapeutic and prophylactic vaccines. Founded in 2017, the company is a joint-venture between NASDAQ First North listed ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines. The goal of the Joint Venture is to create a world-class unit for the development of highly competitive vaccines and therapeutics against infectious diseases, cancer, and immunological disorders. AdaptVac combines ExpreS2ion’s proprietary insect cell expression technology, ExpreS2, with NextGen’s unique expertise in proprietary Virus-Like Particle (VLP) technology, positioning the company as a strong and versatile player in the field of new vaccines and immune therapy. Their last investment round in October 2019 secured a kr800.00K grant investment from Innovation Fund Denmark. Based in Denmark, AdaptVac operates within the industries of Biotechnology and Health Care.

Taxonomy: vaccine development, therapeutic vaccines, prophylactic vaccines, infectious diseases, cancer treatment, immune therapy, virus-like particles, insect cell expression technology, biotech, University of Copenhagen, ExpreS2ion Biotech, NextGen Vaccines, joint venture, immunological disorders

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant kr800.00K 1
Innovation Fund Denmark
17 Oct 2019

AdaptVac Alternatives & Competitors

AdaptVac vs
ACM Biolabs
ACM Biolabs Singapore

ACM Biolabs • Innovative medicines through next generation targeted delivery. • Versatile platform...

Venture round
19 employees
Biotechnology, Health Care
AdaptVac vs
OXFORD VACMEDIX UK LIMITED
OXFORD VACMEDIX UK LIMITED United Kingdom

Developing therapeutic cancer vaccines using ROP technology

Series A
8 employees
Health Care, Health and Wellness
AdaptVac vs
VBI Vaccines Inc.
VBI Vaccines Inc. United States

Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease

Post-IPO Equity
57 employees
Biotechnology, Health Care

FAQ About AdaptVac

AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines
AdaptVac was founded in 2017.
AdaptVac is headquartered in Denmark.
AdaptVac operates in Biotechnology, Health Care and Health and Wellness. Its work centres on vaccine development, therapeutic vaccines, prophylactic vaccines and infectious diseases.
AdaptVac has approximately 10 employees.
AdaptVac has completed 1 funding round, raising a total of $800.00K. The latest funding stage is Grant.
Top alternatives and competitors to AdaptVac include ACM Biolabs, OXFORD VACMEDIX UK LIMITED, VBI Vaccines Inc., Rocketvax AG, RemedyBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AdaptVac and ACM Biolabs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AdaptVac, https://bouncewatch.com/company/adaptvac, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes